Kapil Arya Institution Verified

Sourced from institutional research profiles (UAMS TRI or ARA).

Researcher

University of Arkansas for Medical Sciences

faculty

11 h-index 39 pubs 571 cited

Research Areas

Links

ORCID Lab Website UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Kapil Arya's research focuses on neurological disorders, particularly spinal muscular atrophy (SMA) and Huntington's disease. He has investigated treatment strategies for SMA, including expanded access programs and outcomes in early-treated infants, as detailed in recent publications. Arya also examines advanced drug delivery systems for Huntington's disease, exploring current challenges and opportunities in the field. His work has also addressed seizure frequency and outcomes in patients with myelomeningocele. Arya's scholarship metrics include an h-index of 11, with 39 total publications and 571 total citations. He collaborates with Aravindhan Veerapandiyan at the University of Arkansas for Medical Sciences, with whom he shares one publication.

Metrics

h-index: 11
Publications: 39
Citations: 571

Selected Publications

Essential Components of Child Neurology Training: Program Director Consensus Recommendations (2025) DOI
Outcomes of early‐treated infants with spinal muscular atrophy: A multicenter, retrospective cohort study (2024) DOI
Considerations for Treatment in Clinical Care of Spinal Muscular Atrophy Patients (2024) DOI
An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy (2022) DOI
Frequency, Predictors, and Outcome of Seizures in Patients With Myelomeningocele: Single-Center Retrospective Cohort Study (2021) DOI